Repligen Corp intend file investigational drug application Food Drug Administration seek permission test AIDS vaccine human summer. Repligen human test begin year. "We sufficiently encourage impressed date ahead clinical trial" Michael Egan manager development Repligen biotechnology company. Repligen's Egan vaccine contains subfragment protein coat AIDS virus. In animal test include primate Egan vaccine provoke neutralize antibody AIDS virus broader cellular immunity. Egan approach Repligen use deliver vaccine use standard vaccine method safer vaccine use live smallpox virus carry protein found surface coat AIDS virus. Yesterday Bristol-Myers Co BMY> seek regulatory permission test AIDS vaccine us smallpox virus human month. Repligen's AIDS vaccine collaborative effort company Centocor Inc CNTO> Duke University Medical School National Cancer Insitutes. The research team direct John Ghrayeb Centocor Scott Putney Repligen Dani Bolognesi Duke Robert Gallo Flossie Wong-Staal National Cancer Institute. Although AIDS vaccine candidate expert believe development safe effective vaccine way away. Moreover seek approval test vaccine step process verify vaccine actually prevent infection. Reuter 